Stock Price Quote

VALPLUS BIOTECH LTD.

NSE : NABSE : 526634ISIN CODE : Industry : FloricultureHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1993
Management Info
- Chairman - Managing Director
Registered Office

Address 105, Centre Point,R C Dutt Road,Alkapuri,
Vadodara,
Gujarat-390005

Phone 091-0265- 2339051

Email NA

Website  

Registrars Details
Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE

NEWS

No News Found

Financials

in Millions
QTR Dec 06 ANNUAL 06
Net Profit8.043.12
Gross Profit 8.04 3.12
Operating Profit 8.153.76
Net Sales 10.418.94

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Trescon (BSE)
peergroup  16.95 (5.87%)
M.Cap ( in Cr)121.20
Indrayani Biotech (BSE)
peergroup  54.45 (-1.11%)
M.Cap ( in Cr)247.94

Shareholding Pattern

PROMOTERS 53.29%
NON-INSTITUTION 46.33%
MUTUAL FUNDS/UTI 0.38%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Valplus Biotech Ltd.

Valplus Biotech Ltd. was incorporated in the year 1993. Its today's share price is 0. Its current market capitalisation stands at Rs 0.9 Cr. In the latest quarter, company has reported Gross Sales of Rs. 0 Cr and Total Income of Rs.0 Cr. The company's management includes Sanjay Saraogi, Bhaskar Patel, Shantilal R Patel, Anju Saraogi, Chander R Saraogi, Ravi Gupta, Girish Shah, Mahendra G Patel, Mehul Patel.

It is listed on the BSE with a BSE Code of 526634 , NSE with an NSE Symbol of and ISIN of . It's Registered office is at 105, Centre Point,R C Dutt Road,AlkapuriVadodara-390005, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are SP Vyas & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.